Michael’s breadth of financial experience in the healthcare industry will not only support our current strategic plan, but will also help CSM move forward in the next stage of our global development.
Fargo, ND (PRWEB) July 07, 2015
CSM, a leading clinical trial supply company, today announced that Michael Morse has joined the executive team as Vice President of Finance. Morse has an extensive background in financial management and accounting, bringing over 20 years of experience in the biotechnology and pharmaceutical industries to the CSM team. In his new role, Morse will oversee all financial areas of the company to both strengthen CSM’s financial strategy and meet overall company goals and objectives.
“We welcome Michael to CSM,” said Gerald Finken, CSM’s President and CEO. “I know he will be a tremendous addition to our executive team and continue to raise the bar in our commitment to excellence. Michael’s breadth of financial experience in the healthcare industry will not only support our current strategic plan, but will also help CSM move forward in the next stage of our global development,” said Finken.
With CSM’s growth and continued expansion both in the US and internationally, this role will be crucial in supporting the company’s strategic planning for long-term financial success. As Vice President of Finance, Morse will be responsible for budgeting, forecasting, cash flow management, taxation, and financial planning and reporting.
Prior to joining CSM, Morse was the Director of Finance for Genzyme Corporation, a publicly traded, billion-dollar biopharmaceutical company. During his 10+ years at Genzyme, Morse directed the financial operations of three Research and Development (R&D) units and managed the financial impact of a large-scale clinical trial.
“I am very excited to take on this new role and work closely with CSM’s executive team and key stakeholders,” said Morse. “I look forward to being an integral part of such a fast-growing company and am eager to start contributing.”
Morse is a Certified Public Accountant in Massachusetts and Chartered Global Management Accountant. He holds a BS from Bentley University, an MBA from Boston University, and a Master of Taxation from Bentley University.
CSM provides clinical trial supply services with quality-driven processes to enhance biotechnology and pharmaceutical clinical trials worldwide. The company has continued to evolve with its blend of unique and traditional clinical trial services that improve efficiency and accuracy.
CSM is the innovator of On-Demand Packaging and Labeling services, an industry breakthrough in which clinical supplies are made specifically for, and immediately prior to, each shipment. Some of CSM’s other core services include: traditional packaging and labeling, cold chain logistics, controlled drug services, returns and reconciliation, clinical label printing and global distribution. For more information, visit http://www.csmondemand.com